Early Access — free while we kick the tires
EdgarHawk

NICOLS JOHN J

Director

Director
2 filings analyzed · 1 company · Latest 2025-05-15

Companies

Company Buys Sells Direction
SCIENTIFIC INDUSTRIES INC SCND 2 0 Net buying

Activity

May 2025
low
Buy
15,000 shares
$15,000
Significance 3/10

SCND Director Nicols doubles stake to 30.0K shares with $15.0K buy at $1.00; stock down -64.0% from 52-week high, company unprofitable

Director John J Nicols purchased 15,000 shares at $1.00 on 2025-04-18, doubling his holdings from 15,000 to 30,000 shares. The purchase occurred at a significant discount to the 52-week high of $2.22 and when the stock was trading 30-day down -21.6% and 90-day down -20.8%. The company faces fundamental headwinds: it reported net income of $-1.8M on revenue of $2.4M (latest quarter), remains unprofitable on a full-year basis, and is experiencing annual revenue decline of -3.6%. His prior buy activity at SCND shows a 90-day return of -14.6%, and across all his open-market trades, the 90-day win rate is 0.00%, suggesting a pattern of trades not followed by recovery within the measured window.

July 2024
medium
Buy
15,000 shares
$30,000
Significance 4/10

Director NICOLS JOHN J purchased 15,000 shares at $2.00 on 2023-12-13; company unprofitable with -$2.1M net income, down -2.5% YoY revenue.

Director NICOLS JOHN J purchased 15,000 shares at $2.00 on 2023-12-13, establishing a new position of 15,000 shares. Scientific Industries is unprofitable with a full-year net income of $-2.1M and annual revenue decline of -2.5%, generating only $2.5M in latest quarterly revenue against a market cap of $18.4M. The stock is trading at $1.75, down 63.2% from its 52-week high of $4.75, though it has recovered 35.7% over the past 30 days. An insider initiating a stake in a micro-cap, unprofitable company trading near 52-week lows warrants attention to understand the rationale and any non-public information that may have informed the timing.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access